For many life sciences and health tech vendors, the question of in-house vs agency marketing comes up at a specific inflection point. Your company’s product is live, sales conversations are happening and you’re building momentum. But what worked in marketing when the company was small and scrappy now starts to feel insufficient. You’re starting to feel under-resourced. When this happens, leaders can find themselves spending too much time on day-to-day marketing decisions.
At this stage, marketing needs to become more stable, repeatable, and aligned with revenue. Choosing the right operating model can be challenging. The main goals at this stage are making sure whatever structure you implement aligns with where you are now in your growth journey and can support the next phase of your company’s maturity.
Here we explore some common models to consider, and provide context around benefits and tradeoffs that will help in navigating this decision.
For companies selling into healthcare and life sciences, the choice of marketing structure carries extra weight. Marketing in regulated markets in a more complex enterprise than in others. Compliance demands affect what can be said publicly and how quickly teams can move.
Messaging often requires several levels of review beyond corporate: for example, legal, regulatory, and clinical. Missteps and mistakes happen, slowing momentum. The kind of fast learning loops that can be formed in other environments are far more difficult to create.
These factors lead to another issue: the marketing organization in regulated markets directly impacts credibility. Clear ownership, consistent messaging, and tight alignment between strategy and execution matter more in these environments than in many other B2B markets.
This is especially common for vendors moving from early traction into sustained go-to-market motion.
Most life sciences and healthcare tech teams choose one of these four models, or consider a hybrid approach:
Each model can work well, but they each come with tradeoffs. The real question is not which option is objectively “best,” but which one fits the company’s growth stage, market complexity, and internal leadership capacity.
The first model, in-house marketing. is the most traditional and straightforward model. It tends to be most effective when a company has clear product-market fit and ongoing financial stability. At this stage, the deep domain knowledge and institutional context accumulated by internal teams becomes valuable. Over time, employees gain familiarity with compliance requirements, buyer expectations, and product nuance over time, which can improve operational consistency and help drive growth.
In-house models work when leadership is confident in the company’s strategic direction and prepared to invest long term in both talent and capability. Another benefit is that internal teams can more tightly align with product, sales, legal, and compliance functions. Reviews and approvals can move faster because structure and context live inside the organization. Over time, this continuity supports more consistent messaging, which is a critical foundation for credibility.
In-house functions are premised on building a team internally. Hiring is expensive and can be slow. Beyond salaries, recruiting, onboarding, and ramp time all contribute to added cost. In competitive markets, specialized marketing skills come at a premium. For example, 78% of marketing candidates expect higher compensation for their expertise.
Small internal teams are also easily stretched. As channel needs grow, gaps in skills or capacity can slow execution. Filling those gaps often means additional higher-cost hires. Early go-to-market pivots may feel harder when the team is built for stability rather than flexibility.
For many life sciences and health tech vendors, agencies offer a way to add capacity and specialized skills without building everything internally. Agencies are often most effective when goals are clear and the work well-scoped: launching a demand generation program, standing up new channels, or executing against a defined roadmap.
Agencies provide access to multiple specialists and experts under one roof — strategy, content, paid media, analytics, and technical execution — without requiring the overhead or investment in recruiting permanent hires. In regulated markets, agencies can also bring established, market-specific processes and tools that speed execution once onboarding is complete. For teams with limited internal bandwidth, this can accelerate progress and help grow revenue.
Similar to new hires, agencies need time at the start to acclimate to and build context in partnership with new clients. In regulated environments, onboarding and discovery are not optional, and early progress may feel slower than expected as a result.
Ownership can also become unclear. Without strong internal leadership and explicitly assigned responsibilities, strategy and execution may drift. Decisions may also stall between internal teams and external partners. Agencies tend to work effectively when there is clear internal direction and someone accountable for priorities and approvals.
Fractional CMOs often sit between in-house and agency models. For life sciences and health tech vendors, a fractional CMO can provide senior-level leadership and insight without the cost or commitment of a full-time executive. This is especially useful when the company needs strategic direction but lacks internal marketing expertise at the senior level.
In many cases, a fractional CMO works alongside an agency, translating business goals into execution plans while keeping compliance, buyer needs, and sales alignment in view. This model can make a strong positive impact, but only if roles and decision-making authority are clearly defined from the outset.
Bringing on marketing contractors and freelancers is a common strategy in a company’s early stages. This is also effective in helping a company get through transitions. These professionals can be experts in their fields and are typically brought in for specific functions like content, design, paid media or marketing ops, when the volume of work does not justify a full-time hire.
This model is highly flexible and allows teams to move forward without long hiring cycles or permanent overhead. In regulated markets, contractors can provide targeted expertise while internal processes and approvals mature. They often focus on output and results, which can help maintain momentum during periods of uncertainty or change.
In this model, coordination becomes the biggest challenge. When multiple contractors are involved, context can fragment and internal leaders can end up spending more time than they anticipated on alignment and prioritization. Contractors are usually focused on execution rather than ownership. Strategy, integration, and compliance oversight still sit internally, which can also strain leadership capacity. This model works very well when there are clear scopes, strong internal direction and realistic expectations.
In order to choose the most effective model, vendor leaders need to look at three interrelated factors:
Most differences come down to tradeoffs:
For regulated healthcare and life sciences vendors, the most effective setups connect strategy and execution while maintaining clear ownership.
Choosing between in-house, agency, or fractional marketing is not about finding the perfect model. It is about choosing the structure that fits where the company is today.
If you are evaluating in-house versus agency marketing and want a model designed for regulated healthcare and life sciences, Rebound can offer fractional CMOs and marketing teams who understand your specific challenges and can begin to add value to your business right away.
If you’d like to learn more and see whether this model fits your stage, let’s talk.
How does a fractional marketing team compare to in-house or agency models?
An fractional team blends expertise and continuity with flexibility. Strategy and execution are delivered together, reducing handoffs and misalignment.
When does a fractional CMO make sense?
This model makes sense when a company needs senior marketing leadership but is not ready to hire full-time — common during early go-to-market or growth phases.
Can external teams work alongside internal teams in regulated markets?
Yes. Many are designed as extensions of internal teams while keeping decision-making aligned internally.
Take control of your content – ditch the algorithm and rely on our email newsletter for the latest best practices, trends, and resources.
